Arrowhead Pharmaceuticals’s Return On Capital Employed Overview
Benzinga Pro data, Arrowhead Pharmaceuticals (NASDAQ:ARWR) reported Q4 sales of $31.57 million. Earnings fell to a loss of…
Morgan Stanley Maintains Equal-Weight on Arrowhead Pharmaceuticals, Lowers Price Target to $37
Morgan Stanley analyst Andrew Galler maintains Arrowhead Pharmaceuticals (NASDAQ:ARWR) with a Equal-Weight and lowers the price target from $41 to $37.
SVB Leerink Maintains Market Perform on Arrowhead Pharmaceuticals, Lowers Price Target to $31
SVB Leerink analyst Mani Foroohar maintains Arrowhead Pharmaceuticals (NASDAQ:ARWR) with a Market Perform and lowers the price target from $33 to $31.
Earnings Scheduled For November 28, 2022
Companies Reporting Before The Bell
• Pinduoduo (NASDAQ:PDD) is projected to report quarterly earnings at $0.65 per share on revenue of $4.31 billion.
SVB Leerink Maintains Market Perform on Arrowhead Pharmaceuticals, Raises Price Target to $33
SVB Leerink analyst Mani Foroohar maintains Arrowhead Pharmaceuticals (NASDAQ:ARWR) with a Market Perform and raises the price target from $32 to $33.
Morgan Stanley Initiates Coverage On Arrowhead Pharmaceuticals with Equal-Weight Rating, Announces Price Target of $41
Morgan Stanley analyst Andrew Galler initiates coverage on Arrowhead Pharmaceuticals (NASDAQ:ARWR) with a Equal-Weight rating and announces Price Target of $41.
Arrowhead Files For Regulatory Clearance To Initiate Phase 1/2a Study Of ARO-MMP7 For Idiopathic Pulmonary Fibrosis
Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) today announced that it has filed an application for clearance to initiate a Phase 1/2a clinical trial of ARO-MMP7, the company's investigational RNA interference (RNAi)
ARWR: Phase 1/2a Clinical Trials Underway for Pulmonary Disease Candidates…
By David Bautz, PhD
NASDAQ:ARWR
READ THE FULL ARWR RESEARCH REPORT
What 7 Analyst Ratings Have To Say About Arrowhead Pharmaceuticals
Analysts have provided the following ratings for Arrowhead Pharmaceuticals (NASDAQ:ARWR) within the last quarter: